How does 68 Ga‐prostate‐specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?-Reference-Cited by-同舟云学术

How does 68 Ga‐prostate‐specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?

Published:2019-05-13 Issue:8 Volume:26 Page:804-811
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Bianchi Lorenzo¹²,Schiavina Riccardo¹²,Borghesi Marco¹²,Ceci Francesco³⁴,Angiolini Andrea¹,Chessa Francesco¹,Droghetti Matteo¹,Bertaccini Alessandro¹²,Manferrari Fabio¹²,Marcelli Emanuela²³⁴⁵,Cochetti Giovanni⁶,Porreca Angelo⁷,Castellucci Paolo³,Fanti Stefano³,Brunocilla Eugenio¹²

Affiliation:

1. Department of Urology S. Orsola‐Malpighi University Hospital University of Bologna Bologna Italy

2. Department of Specialist, Diagnostic and Experimental Medicine University of Bologna Bologna Italy

3. Metropolitan Nuclear Medicine S. Orsola‐Malpighi University Hospital University of Bologna Bologna Italy

4. Ahmanson Translational Imaging Division Department of Molecular and Medical Pharmacology University of California at Los Angeles Los Angeles California USA

5. Laboratory of Bioengineering Department of Experimental Diagnostic and Specialty Medicine University of Bologna Bologna Italy

6. Department of Surgical and Biomedical Sciences Institute of Urological Andrological Surgery and Minimally Invasive Techniques Perugia Italy

7. Department of Urology Abano Terme Hospital Padua Italy

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14012

Reference27 articles.

1. Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis

2. 68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients